Mexico - Delayed Quote MXN

Inovio Pharmaceuticals, Inc. (INO.MX)

Compare
40.00
0.00
(0.00%)
At close: February 28 at 8:41:37 AM CST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
203.41
832.01
10,262.27
1,774.76
7,411.22
Operating Expense
119,626.51
134,258.67
277,835.79
302,992.68
131,493.26
Operating Income
-119,423.10
-133,426.66
-267,573.52
-301,217.92
-124,082.04
Net Non Operating Interest Income Expense
5,273.39
6,910.50
3,528.08
1,426.63
-5,390.60
Other Income Expense
1,273.63
-8,601.20
-13,607.41
-3,433.04
-33,417.66
Pretax Income
-112,876.09
-135,117.35
-277,652.85
-303,224.32
-162,890.30
Earnings from Equity Interest Net of Tax
--
--
-2,165.21
-434.39
-4,584.61
Net Income Common Stockholders
-112,876.09
-135,117.35
-279,818.07
-303,658.71
-166,411.16
Diluted NI Available to Com Stockholders
-112,876.09
-135,117.35
-279,818.07
-303,658.71
-166,411.16
Basic EPS
-4.43
-6.09
-14.04
-17.45
-12.84
Diluted EPS
-4.43
-6.09
-14.04
-17.45
-12.84
Basic Average Shares
25,346.27
22,173.66
19,885.18
17,402.48
12,927.24
Diluted Average Shares
25,346.27
22,173.66
19,885.18
17,402.48
12,927.24
Total Operating Income as Reported
-119,423.10
-143,940.03
-267,573.52
-301,217.92
-124,082.04
Total Expenses
119,626.51
134,258.67
277,835.79
302,992.68
131,493.26
Net Income from Continuing & Discontinued Operation
-112,876.09
-135,117.35
-279,818.07
-303,658.71
-166,411.16
Normalized Income
-116,615.76
-130,454.61
-271,971.89
-300,435.87
-97,141.74
Interest Income
5,733.55
8,133.29
4,782.03
3,363.08
3,311.85
Interest Expense
460.16
1,222.79
1,253.95
1,936.45
8,702.45
Net Interest Income
5,273.39
6,910.50
3,528.08
1,426.63
-5,390.60
EBIT
-112,415.93
-133,894.56
-276,398.90
-301,287.88
-154,187.85
EBITDA
-109,886.49
-130,391.03
-270,902.87
-296,557.10
-149,560.06
Reconciled Depreciation
2,529.44
3,503.54
5,496.03
4,730.78
4,627.79
Net Income from Continuing Operation Net Minority Interest
-112,876.09
-135,117.35
-279,818.07
-303,658.71
-166,411.16
Total Unusual Items Excluding Goodwill
3,739.68
-4,662.75
-7,846.17
-3,222.84
-69,269.42
Total Unusual Items
3,739.68
-4,662.75
-7,846.17
-3,222.84
-69,269.42
Normalized EBITDA
-113,626.16
-125,728.28
-263,056.70
-293,334.26
-80,290.65
12/31/2020 - 3/24/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers